Sarah J. Fidler

Sarah J. Fidler

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 296 publications

Discordance Between Biomarker-Confirmed Antiretroviral Therapy and Self-Reported HIV Status Among People Living with HIV in Zambia and South Africa: A Secondary Analysis of HPTN 071 (PopART).

Discordance Between Biomarker-Confirmed Antiretroviral Therapy and Self-Reported HIV Status Among People Living with HIV in Zambia and South Africa: A Secondary Analysis of HPTN 071 (PopART).

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Prior PrEP use and discontinuation in individuals newly diagnosed with HIV.

Prior PrEP use and discontinuation in individuals newly diagnosed with HIV.

Journal: HIV medicine

Published: March 27, 2026

The age and sex dynamics of heterosexual HIV transmission in Zambia: an HPTN 071 (PopART) phylogenetic and modelling study.

The age and sex dynamics of heterosexual HIV transmission in Zambia: an HPTN 071 (PopART) phylogenetic and modelling study.

Journal: medRxiv : the preprint server for health sciences

Published: March 23, 2026

The process of developing an HIV disclosure intervention for youth with perinatally acquired HIV: The HIV Empowering Adults' Decisions to Share - UK/Uganda Project (Heads-Up).

The process of developing an HIV disclosure intervention for youth with perinatally acquired HIV: The HIV Empowering Adults' Decisions to Share - UK/Uganda Project (Heads-Up).

Journal: Global public health

Published: March 09, 2026

Risk factors associated with adverse metabolic health in youth with perinatally acquired HIV living in the United Kingdom.

Risk factors associated with adverse metabolic health in youth with perinatally acquired HIV living in the United Kingdom.

Journal: AIDS (London, England)

Published: February 12, 2026

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

"If there was no stigma around it, I would tell people": perspectives of UK youth living with perinatally acquired HIV, their social networks and healthcare professionals on HIV status sharing.

"If there was no stigma around it, I would tell people": perspectives of UK youth living with perinatally acquired HIV, their social networks and healthcare professionals on HIV status sharing.

Journal: AIDS care

Published: January 21, 2026

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Journal: The lancet. HIV

Published: December 09, 2025

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART.

Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART.

Journal: HIV medicine

Published: October 02, 2025

Migration and its impact on universal HIV testing and treatment in the HPTN 071 (PopART) study communities.

Migration and its impact on universal HIV testing and treatment in the HPTN 071 (PopART) study communities.

Journal: PLOS global public health

Published: September 25, 2025

Showing 1-12 of 296

Last Updated: 09/26/2026